trié(s) par (Pertinence décroissant(e), Titre croissant(e)) 

Article

Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial

Inmaculada Moreno ; Antonio Belinchon |

Dans Ear and hearing (Vol.43, n°2, Mars-avril 2022)

Objective: To determine the efficacy of long-term high-dose intratympanic dexamethasone in protecting the hearing capacity of cancer patients undergoing cisplatin-based ototoxic treatment. Design: A randomized controlled phase IIIB clinical tri[...]

Plus d'information... En ligne